Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated from Lab Vision

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> PRODUCTS

Products	Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated from Lab Vision
Company	Lab Vision
Item	Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated
Price	$139.00
Description	Factor XIII in both reduced and non-reduced forms. It does not react with human Factor XIII B-chain or human Factor XII. Factor XIII is a Beta-globulin found in plasma and is composed of two subunits. Factor XIII-A is the catalytic subunit and is a dimmer of M.W. 160kDa. Factor XIII is present in plasma as an Alpha2Beta2 heterodimer (M.W. 320kDa); whereas in platelets, only the Alpha2 unit exists. Factor XIIIa is a dermal dendrocyte marker and shows variable reaction with these types of tumors. It can be used for histiocytic phenotyping and has been reported to mark capillary hemangiomas and tumors of the central nervous system. Factor XIII has also been used with CD34 to differentiate between dermatofibroma and dermatofibrosarcoma protuberans. Species Reactivity: Human. Others-not tested.
Info	Lab Vision 47777 Warm Springs Blvd. Fremont, CA 94539 Customer Service: 800-828-1628 Fax Number: 510-991-2826 Web Site: http://www.labvision.com

NOTE: Price information is approximate list price and actual prices may vary.

... Glucagon-like peptide-1(7-36) amide (GLP-1), C-terminal ... but shows <0.1% cross reactivity with ... or other related peptides such as ... Most mammalian species. GLP-1 is identical ...

Lineage cocktail 1 (lin 1) 50 tests...

BAI-1 (T-20)...

MOUSE ANTI HUMAN CYTOKERATIN 1-8...

Biology Products:

Anti-GLP-1 (7-36) (Glucagon-like peptide-1), C-terminus amide-reactive Polyclonal Antibody, Unconjugated from CHEMICON Anti-Lineage 1 (lin 1) Cocktail Monoclonal Antibody, FITC Conjugated from BD Biosciences - Immunocytometry Systems Goat Anti-BAI-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Mouse Anti-Human CYTOKERATIN 1-8 Monoclonal Antibody, Unconjugated, Clone Ks1-8 from AbD Serotec

(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...

(Date:3/31/2016)... , March 31, 2016 Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...

(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...

Breaking Biology News(10 mins):

[0] BioCatch Appoints Eyal Goldwerger as CEO [1] Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team [0] Electronic Sensors Market for Consumer Industry Worth 26.76 Billion USD by 2022

(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...

(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...

(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...

(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...

Breaking Biology Technology:

[0] Epic Sciences Introduces Sensitive HRD Liquid Biopsy Test for PARP Inhibitor Clinical Trials [0] Doctors Say Earlier Mesothelioma Diagnosis Might Be Possible with MicroRNAs, According to Surviving Mesothelioma [0] UAS LifeSciences Announces the Launch of UP4™ Probiotics into Target Stores Nationwide [0] Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers